These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1608013

  • 1. Current trends in blood component therapy: the evolution of a safer, more effective product.
    Baranowski L.
    J Intraven Nurs; 1992; 15(3):136-51. PubMed ID: 1608013
    [Abstract] [Full Text] [Related]

  • 2. Current and future trends in transfusion therapy.
    Rossetto CL, McMahon JE.
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):160-73. PubMed ID: 10944864
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood transfusion.
    Nerlich S.
    Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966
    [Abstract] [Full Text] [Related]

  • 7. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG.
    Clin Lab Sci; 2003 Jun; 16(2):115-9. PubMed ID: 12757192
    [Abstract] [Full Text] [Related]

  • 8. [Labile blood products and their preparation].
    Chabanel A, Folléa G.
    Rev Prat; 2001 Jun 30; 51(12):1306-10. PubMed ID: 11503503
    [Abstract] [Full Text] [Related]

  • 9. Leukocyte-poor blood components: issues and indications.
    Lichtiger B, Leparc GF.
    Crit Rev Clin Lab Sci; 1991 Jun 30; 28(5-6):387-403. PubMed ID: 1772586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Supportive therapy with blood components].
    Höcker P.
    Wien Med Wochenschr; 1991 Jun 30; 141(9-10):209-12. PubMed ID: 1949846
    [Abstract] [Full Text] [Related]

  • 12. [Blood products].
    Montloin A.
    Rev Infirm; 1992 Mar 30; 42(6):33-41. PubMed ID: 1598492
    [No Abstract] [Full Text] [Related]

  • 13. Blood component replacement therapy.
    Coffland FI, Sheleton DM.
    Crit Care Nurs Clin North Am; 1993 Sep 30; 5(3):543-56. PubMed ID: 8217049
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives.
    Seghatchian J.
    Transfus Apher Sci; 2008 Aug 30; 39(1):49-50. PubMed ID: 18617442
    [No Abstract] [Full Text] [Related]

  • 17. [Essential standards of mechanical autologous donation and transfusion].
    Paravicini D.
    Beitr Infusionsther; 1991 Aug 30; 28():341-7. PubMed ID: 1725652
    [Abstract] [Full Text] [Related]

  • 18. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
    Nikolov A, Kovachev I, Gŭrcheva L, Dimitrov A.
    Akush Ginekol (Sofiia); 1998 Aug 30; 37(4):46-9. PubMed ID: 10360055
    [No Abstract] [Full Text] [Related]

  • 19. [Current technologies for blood loss prevention during abdominal hysterectomy].
    Fedorova TA, Ragimov AA, Bogomazova IV, Rogachevskiĭ OV, Dzhabrailova DA.
    Anesteziol Reanimatol; 2007 Aug 30; (6):48-51. PubMed ID: 18326259
    [Abstract] [Full Text] [Related]

  • 20. Blood component therapy in obstetrics.
    Fuller AJ, Bucklin B.
    Obstet Gynecol Clin North Am; 2007 Sep 30; 34(3):443-58, xi. PubMed ID: 17921009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.